Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall Conference
BOULDER, CO / ACCESSWIRE / November 3, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid (HOCl) products for a wide range of …
BOULDER, CO / ACCESSWIRE / November 3, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants, today announced the U.S. launch of its intraoperative pulse lavage irrigation treatment, which can replace commonly used IV bags in a variety of surgical procedures.
Sonoma previously launched its pulse lavage irrigation treatment solution in Europe and is introducing this product to the United States at the Symposium on Advanced Wound Care (SAWC) Fall Conference in Las Vegas. Demonstrations will be available November 3-5 at booth 118. The product is expected to be ready for commercial use in the U.S. in November 2023.
Sonoma developed this new application of its wound care technology in response to an unmet need for a non-toxic irrigation solution that can prevent infection and improve healing time. This product replaces commonly used non-antimicrobial saline and aggressive rinsing solutions with safe and effective Microcyn Technology. Microcyn Technology assists in the reduction of microorganisms, is non-toxic, and has regenerative properties, making it critical in preventing infection and promoting wound healing. Sonoma's pulse lavage container is also cost competitive with IV bags, the current standard of care.
The new application complements a variety of pulse lavage irrigation treatments, including abdominal, laparoscopic, and periprosthetic joint infection procedures. The intraoperative pulse lavage irrigation treatment is safe for soft tissues, mucous membranes, bones, tendons, muscles, cartilage and even nerve tissue. The solution can be easily disposed without biohazard precautions and comes in a spikeable and unbreakable 5-liter container.
Lesen Sie auch
"Sonoma continues to lead in the innovation of products that improve healing times and prevent infection, while being safe for all parts of the body," said Amy Trombly, CEO of Sonoma Pharmaceuticals. "Our irrigation solution is an opportunity to fulfill the unmet need of combined safety, effectiveness and convenience in intraoperative pulse lavage irrigation treatments, and we are excited to bring this new technology to the United States medical community."